Headquartered in Conshohocken, PA Fiscal year ends December NASDAQ: AHCO adapthealth.com
AdaptHealth Corp. (NASDAQ: AHCO) provides healthcare-at-home solutions, including home medical equipment, medical supplies and related services. It operates three reportable segments:
- Sleep Health: CPAP and BiLevel equipment, supplies and services for obstructive sleep apnea.
- Respiratory Health: oxygen and home mechanical ventilation equipment, supplies and chronic therapy services for conditions such as COPD and chronic respiratory failure.
- Wellness at Home: home medical equipment, essential medical supplies and durable medical equipment for patients discharged from acute care and other facilities, or managing complex disease states.
In July 2026 the company agreed to sell its Diabetes Health business for $235.0 million in cash. That business is now reported as discontinued operations, and the sale is expected to close in early 2027.
AdaptHealth gets patients through referral sources such as acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities and clinics. It also increasingly uses capitated and preferred-provider agreements with health systems and health plans, including an exclusive capitated agreement with a large national integrated delivery network.
It serves Medicare, Medicaid and commercial insurance beneficiaries, reaching about 4.8 million patients annually in all 50 states through roughly 660 locations in 48 states. It is also building digital patient engagement tools, including the myAPP app and an AI-powered mask-fitting tool. Updated
Consumer confidence is breaking down in a way investors have not seen in years. The University of Michigan Consumer Sentiment Index landed at 53.3 in March 2026, sitting below the 60 recessionary…
Three beneficial owners filed open-market purchases this past week, each targeting a stock under significant pressure. General Atlantic accumulated shares in Alkami Technology (NASDAQ: ALKT) across three consecutive sessions. Richard Cashin stepped…
Thursday's top analyst upgrades and downgrades included Airbnb, Alcon, Antero Midstream, Exact Sciences, GitLab, GlobalFoundries, Halozyme Therapeutics, Lumentum, Nektar Therapeutics, PayPal and Southern Copper.
Wednesday's top analyst upgrades and downgrades included Carnival, Conagra Brands, Duke Energy, Estee Lauder, Gap, Lululemon Athletica, Nokia and Tesla.
AdaptHealth Corp. (NASDAQ: AHCO) provides healthcare-at-home solutions, including home medical equipment, medical supplies and related services.
The Wall Street consensus 12-month price target for AHCO is $8.86.
